Back to results

Novel melanoma antigen peptide and uses thereof

The invention relates to peptides derived from the MELOE antigen for therapeutic vaccination against cancer. A phase I clinical trial for ex-vivo therapy of melonama is ongoing.
Keywords: MELOE, antigen, cancer, melanoma, TIL, vaccination
Patent Application number: International Procedure (PCT) - 22 Mai 2012 - PCT/IB2012/001310
Inventors:
ROGEL AnneLANG FrançoisBOBINET Mathilde
Publications:
null

Reference:

BIO12113-T1

    Business Developper
    contact
    Elodie Acloque
    Business Developer
    Patent filling date: 22-05-2012
    Rare disease: No
    Second indication: No

    You might also be interested in